Description
Therapeutic Segment: Anti-Diabetic
Generic Name: Pioglitazone HCl
Indication:As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus as:
- Monotherapy in patients (particularly overweight patients) inadequately controlled by diet and exercise for whom metformin is inappropriate because of contraindications or intolerance.
- Dual oral therapy in combination with:
• Metformin, in patients (particularly overweight patients) with insufficient glycaemic control despite maximal tolerated dose of monotherapy with metformin.
• Sulphonylurea, only in patients who show in tolerance to metformin or for whom metformin is contraindicated, with insufficient glycaemic control despite maximal tolerated dose of monotherapy with a sulphonylurea. - Triple oral therapy in combination with:
Metformin and a sulphonylurea, in patients (particularly overweight patients) with insufficient glycaemic control despite dual oral therapy. - Also indicated for combination with insulin in type 2 diabetes mellitus patients with insufficient glycaemic
control on insulin for whom metformin is inappropriate because of contraindications or intolerance.
Additional information
| brand | Getz Pharma |
|---|
